November 28, 2002New England Journal of MedicineOpen Access

Specific Removal of β₁-Adrenergic Autoantibodies from Patients with Idiopathic Dilated Cardiomyopathy

View Full Paper

Ask AI

Bookmark

Authors

GWGerd WallukatHeart Failure / Cardiomyopathy JMJohannes MüllerBerlin Heart (Germany)RHRoland HetzerCardiac Surgery

Discussion

Member takes

Implication

Pathophysiologic role of cardiac autoantibodies in idiopathic dilated cardiomyopathy remains unclear; leaves open therapeutic targeting pending higher-level evidence.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wallukat et al. (2002) studied this question.

synapsesocial.com/papers/6a70092f26a7f98052dc8eab https://doi.org/10.1056/nejm200211283472220

View Full Paper

Ask AI

Bookmark

Implication

Pathophysiologic role of cardiac autoantibodies in idiopathic dilated cardiomyopathy remains unclear; leaves open therapeutic targeting pending higher-level evidence.

Specific Removal of β₁-Adrenergic Autoantibodies from Patients with Idiopathic Dilated Cardiomyopathy

Discussion

Member takes

Implication

Key Points

Cite This Study

Specific Removal of β₁-Adrenergic Autoantibodies from Patients with Idiopathic Dilated Cardiomyopathy

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider